Intravenous immunoglobulin — Indications and mechanisms in cardiovascular diseases

Shoenfeld, 2004, i.v.IG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients, J Clin Immunol, 24, 107, 10.1023/B:JOCI.0000019809.55787.ec

Aukrust, 2004, Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin, Autoimmun Rev, 3, 221, 10.1016/S1568-9972(03)00103-4

Munger, 1996, Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol, 77, 723, 10.1016/S0002-9149(97)89206-5

Aukrust, 2006, The role of intravenous immunoglobulin in the treatment of chronic heart failure, Int J Cardiol, 112, 40, 10.1016/j.ijcard.2006.05.015

Gullestad, 2001, Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure, Circulation, 103, 220, 10.1161/01.CIR.103.2.220

Gullestad, 2005, Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches, Am J Cardiol, 95, 17C, 10.1016/j.amjcard.2005.03.008

Mobini, 2004, New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy, Autoimmun Rev, 3, 277, 10.1016/j.autrev.2003.10.005

Nussinovitch U, Shoenfeld Y: Autoimmune Dilated Cardiomyopathy. in Shoenfeld Y., Cervera R., Gershwin M. (eds): Diagnostic Criteria for the Autoimmune Diseases. New Jersey, USA: The Humana Press Inc, In Press.

Blum, 2001, Pathophysiological role of cytokines in congestive heart failure, Annu Rev Med, 52, 15, 10.1146/annurev.med.52.1.15

McNamara, 1997, Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy, Circulation, 95, 2476, 10.1161/01.CIR.95.11.2476

Larsson, 2004, Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody, Autoimmunity, 37, 489, 10.1080/08916930400011684

Stork, 2006, Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy, Am Heart J, 152, 697, 10.1016/j.ahj.2006.05.004

McNamara, 2001, Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy, Circulation, 103, 2254, 10.1161/01.CIR.103.18.2254

Bozkurt, 1999, Intravenous immune globulin in the therapy of peripartum cardiomyopathy, J Am Coll Cardiol, 34, 177, 10.1016/S0735-1097(99)00161-8

Amabile, 2006, Outcome of acute fulminant myocarditis in children, Heart, 92, 1269, 10.1136/hrt.2005.078402

Stouffer, 2003, The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin, Am J Med Sci, 326, 369, 10.1097/00000441-200312000-00013

Takada, 1995, Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects, Circulation, 92, 1604, 10.1161/01.CIR.92.6.1604

Kishimoto, 2003, Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress, Int J Cardiol, 91, 173, 10.1016/S0167-5273(03)00002-0

Drucker, 1994, Gamma-globulin treatment of acute myocarditis in the pediatric population, Circulation, 89, 252, 10.1161/01.CIR.89.1.252

Kalpatthi, 2004, Heart block in infant with atypical myocarditis: a case report and review of literature, Int J Cardiol, 96, 113, 10.1016/j.ijcard.2003.06.007

Sherer, 1999, Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus, Clin Rheumatol, 18, 238, 10.1007/s100670050091

Robinson, 2005, A systematic review of intravenous gamma globulin for therapy of acute myocarditis, BMC Cardiovasc Disord, 5, 12, 10.1186/1471-2261-5-12

Peterlana, 2005, Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases, Clin Rheumatol, 24, 18, 10.1007/s10067-004-0959-7

Tona, 2003, Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment, Ital Heart J, 4, 64

Ozdogu, 2005, Fatal cardiac tamponade in a patient with Kawasaki disease, Heart Lung, 34, 257, 10.1016/j.hrtlng.2004.12.003

Meissner, 2000, Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis, Rheumatol Int, 19, 199, 10.1007/s002960000053

Sherer, 2002, Immunomodulation for treatment and prevention of atherosclerosis, Autoimmun Rev, 1, 21, 10.1016/S1568-9972(01)00003-9

Krause, 2005, Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions, Methods Mol Med, 109, 403

Mallat, 1999, Protective role of interleukin-10 in atherosclerosis, Circ Res, 85, e17, 10.1161/01.RES.85.8.e17

Matsuura, 2005, Intravenous immunoglobulin and atherosclerosis, Clin Rev Allergy Immunol, 29, 311, 10.1385/CRIAI:29:3:311

Wu, 2003, Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations—possible immunomodulation of atherosclerosis, Autoimmunity, 36, 91, 10.1080/0891693031000080228

Shapiro, 2002, Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages, Cancer, 95, 2032, 10.1002/cncr.10905

Voss, 2001, Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial, Circulation, 103, 401, 10.1161/01.CIR.103.3.401

Cilliers, 2003, Anti-inflammatory treatment for carditis in acute rheumatic fever, Cochrane Database Syst Rev, CD003176

John, 1999, Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients, Circulation, 100, II229, 10.1161/01.CIR.100.suppl_2.II-229

Leech, 2006, Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin, Clin Transplant, 20, 476, 10.1111/j.1399-0012.2006.00509.x

Meyer, 2007, Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery, J Thorac Cardiovasc Surg, 133, 1517, 10.1016/j.jtcvs.2006.12.019

Katz, 2007, Safety of intravenous immunoglobulin (IVIG) therapy, Autoimmun Rev, 6, 257, 10.1016/j.autrev.2006.08.011

Kazatchkine, 2001, Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin, N Engl J Med, 345, 747, 10.1056/NEJMra993360

Bayry, 2007, Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action, Nat Clin Pract Rheumatol, 3, 262, 10.1038/ncprheum0481